Time-gated Diffuse Correlation Spectroscopy Consciousness Detection System

freshidea, https://stock.adobe.com/uk/97571889, stock.adobe.com
Background
Assessing consciousness and brain function in critically ill, brain-injured patients poses a significant challenge. Traditional clinical evaluations rely heavily on behavioral responses, which are frequently unreliable in sedated or paralyzed patients and risk missing covert consciousness in unresponsive or minimally conscious individuals. Advanced neuroimaging techniques (e.g., fMRI/PET) can offer deep insights into brain activity, but their application in intensive care is constrained by non-portable equipment, the risks of patient transport, and their unfeasibility for continuous monitoring. At the same time, current bedside modalities have distinct limitations: EEG alone provides limited insight into perfusion and neurovascular coupling, while other non-invasive tools lack the depth penetration and sensitivity needed to accurately capture subtle physiological markers deep within the adult brain. Consequently, there is a pressing need for portable, sensitive, and objective tools that can reliably differentiate levels of consciousness and brain reactivity—even in patients unable to follow commands—to guide treatment and prognosis in these vulnerable populations.
Technology
Researchers at Stony Brook University developed a non-invasive 1064 nm time-domain diffuse correlation spectroscopy (TD-DCS) system. By utilizing temporal time-gating to isolate cortical signals from superficial scalp noise, the platform directly measures microvascular cerebral blood flow (CBF) dynamics—specifically blood-flow index (BFI) and low-frequency oscillations (LFO)—alongside co-located EEG metrics (alpha-delta ratio and total power). In clinical testing, resting-state LFO power systematically declined with severity of consciousness impairment (healthy -> MCS -> coma), while an auditory command task ("smile") revealed blunted or decaying hemodynamic responses in non-responsive patients. Fusing optical CBF and EEG signals via a Random Forest classifier yielded an ROC-AUC of 0.86 and 82% accuracy in a 35-patient retrospective study—representing up to a 69% performance boost over EEG alone. This provides a repeatable, depth-specific bedside tool for detecting covert consciousness without relying on oxygenation surrogates.
Advantages
- Enhanced depth sensitivity
- Higher signal-to-noise ratio (SNR)
- Non-invasive bedside monitoring
- Improved detection of low-frequency oscillations (LFOs)
- Assessment of functional brain reactivity
Application
- Clinical Neurological Assessment and Monitoring
- Functional Brain Reactivity and Physiological Monitoring
- Neurological Research and Drug Development
- Anesthesia Depth Monitoring
Inventors
Ulas Sunar, EIP Professor, BME
Sahar Sabaghian, PhD Student, BME
Licensing Potential
Development partner - Commercial partner - Licensing
Licensing Status
Available
Licensing Contact
Jillian True, Licensing Specialist, Intellectual Property Partners, Jillian.True@stonybrook.edu,
Patent Status
Patent Application Filed
Stage of Development
Prototype Available
Tech ID
050-9538
